Category : Search result: Akums Drugs and Pharmaceuticals


Indian Pharma Firms Eye Licensing Deals for Obesity Drugs

As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.

Bengaluru engineer arrested for making drugs at home

A Bengaluru software engineer was arrested for allegedly manufacturing synthetic drugs like MDMA in a makeshift home laboratory. Police seized drugs worth lakhs and equipment. Read the shocking details.

Senior Exec Quits Job Over Delhi's Toxic Air Pollution

A senior pharmaceutical executive resigns, citing Delhi's severe air pollution as the primary reason. This drastic move highlights the city's escalating public health emergency. Read more about the human cost of India's air quality crisis.

Delhi Pollution Leads to High-Profile Resignation

Rajkumar Bafna, President of Finance at Akums Drugs, resigns citing Delhi's toxic air. His case highlights a growing trend of professionals leaving the capital for health reasons. Read the full story.

New baldness drug shows strong phase 3 results

Cosmo Pharmaceuticals' clascoterone 5% solution shows significant hair regrowth in men with androgenetic alopecia. Could be the first new treatment mechanism in over three decades. Read more.

GLP-1 Drugs Show Benefits Beyond Weight Loss

New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.

India-NZ FTA to Boost Exports Across Key Sectors

The India-New Zealand Free Trade Agreement is set to significantly boost Indian exports in textiles, pharmaceuticals, engineering, agriculture, and services. Learn how this pact will impact trade.

Lack of Drug Inspectors Hampers Action on Spurious Drugs

A severe shortage of drug inspectors is hampering enforcement against spurious and adulterated medicines in India. Officials admit the staffing crisis is a major hurdle. Read more on the critical public health issue.

Himachal Leads Nation in Substandard Drugs: 49 Fail

Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.

Page 1 of 4